Finding new blood tests for ovarian and lung cancer detection
High-throughput immunoproteomics for cancer biomarker discovery
This study is looking to make blood tests better at spotting ovarian and lung cancers by finding special markers related to the immune system, which could help doctors detect these cancers more accurately.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arizona State University-Tempe Campus NIH-funded |
| Lab location | 1 site (Tempe, United States) |
| Project ID | NIH-10927275 on NIH RePORTER |
What this research studies
This research aims to enhance the screening process for ovarian and lung cancers by identifying immune biomarkers present in the blood. The approach involves analyzing how cancer alters protein expressions and how these changes trigger the immune system to produce specific antibodies. By utilizing advanced immunoproteomics technology, the study will explore various types of antibodies, including those against microbial antigens and autoantibodies, to improve the accuracy of cancer detection. The research builds on previous successful findings and aims to develop reliable blood tests that can be used in clinical settings.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at high risk for ovarian or lung cancer, such as those with a family history or specific genetic predispositions.
Not a fit: Patients with cancers other than ovarian or lung cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and earlier detection of ovarian and lung cancers, potentially improving patient outcomes.
How similar studies have performed: Previous research has successfully validated similar approaches in cancer biomarker discovery, indicating a promising potential for this study.
Where this research is happening
Tempe, United States
- Arizona State University-Tempe Campus — Tempe, United States (Active)
Researchers
- Principal investigator: Labaer, Joshua — Arizona State University-Tempe Campus
- Study coordinator: Labaer, Joshua
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.